These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11252254)

  • 1. Antimicrobial activity against obligate intracellular bacteria.
    Raoult D
    Trends Microbiol; 2001 Jan; 9(1):14. PubMed ID: 11252254
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis.
    Rolain JM; Maurin M; Bryskier A; Raoult D
    Antimicrob Agents Chemother; 2000 May; 44(5):1391-3. PubMed ID: 10770788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obligate intracellular bacteria and antibiotic resistance.
    McOrist S
    Trends Microbiol; 2000 Nov; 8(11):483-6. PubMed ID: 11121750
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenic rickettsiae as bioterrorism agents.
    Azad AF
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S52-5. PubMed ID: 17582570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of in vitro susceptibilities of Rickettsia prowazekii, R. rickettsii, R. sibirica and R. tsutsugamushi to antimicrobial agents].
    Miyamura S; Ohta T; Tamura A
    Nihon Saikingaku Zasshi; 1989 Sep; 44(5):717-21. PubMed ID: 2512394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic sensitivity of the erythromycin-resistant strain E of Rickettsia prowazekii cultured in the vector's body].
    Klimchuk ND; Kitsara MS; Frolova OM; Balaeva NM
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):41-5. PubMed ID: 3922182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of antibiotics and combined preparations on the toxic properties of Rickettsia prowazekii].
    Klimchuk ND
    Mikrobiol Zh; 1978; 40(4):482-7. PubMed ID: 102906
    [No Abstract]   [Full Text] [Related]  

  • 8. The in-vitro anti-rickettsial activity of macrolides.
    Keysary A; Itzhaki A; Rubinstein E; Oron C; Keren G
    J Antimicrob Chemother; 1996 Oct; 38(4):727-31. PubMed ID: 8937968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of axenic media to determine antibiotic efficacy against coxiella burnetii.
    Clay KA; Hartley MG; Russell P; Norville IH
    Int J Antimicrob Agents; 2018 May; 51(5):806-808. PubMed ID: 28802854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline.
    Rolain JM; Lambert F; Raoult D
    Ann N Y Acad Sci; 2005 Dec; 1063():252-6. PubMed ID: 16481522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of a method of estimating the count of viable Rickettsia prowazekii for the screening of efficacious antibiotics].
    Predtechenskiĭ AB; Filipenko GN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):3-5. PubMed ID: 9245137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility determination for six strains of Coxiella burnetii MST 17 from Cayenne, French Guiana.
    Eldin C; Perreal C; Mahamat A; Djossou F; Edouard S; Raoult D
    Int J Antimicrob Agents; 2015 Nov; 46(5):600-2. PubMed ID: 26391379
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro susceptibility to tetracycline and fluoroquinolones of Japanese isolates of Coxiella burnetii.
    Andoh M; Naganawa T; Yamaguchi T; Fukushi H; Hirai K
    Microbiol Immunol; 2004; 48(9):661-4. PubMed ID: 15383702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.
    Helgren TR; Chen C; Wangtrakuldee P; Edwards TE; Staker BL; Abendroth J; Sankaran B; Housley NA; Myler PJ; Audia JP; Horn JR; Hagen TJ
    Bioorg Med Chem; 2017 Feb; 25(3):813-824. PubMed ID: 28089350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetii.
    Maurin M; Raoult D
    J Antimicrob Chemother; 1997 Jun; 39(6):725-30. PubMed ID: 9222041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA gyrase and topoisomerase IV mutations in an in vitro fluoroquinolone-resistant Coxiella burnetii strain.
    Vranakis I; Sandalakis V; Chochlakis D; Tselentis Y; Psaroulaki A
    Microb Drug Resist; 2010 Jun; 16(2):111-7. PubMed ID: 20438350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.
    Gikas A; Spyridaki I; Scoulica E; Psaroulaki A; Tselentis Y
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3276-8. PubMed ID: 11600400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug activity against Coxiella burnetii, a pathogen of Q fever].
    Tokarevich NK
    Antibiot Khimioter; 2007; 52(1-2):46-56. PubMed ID: 18461810
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of antibiotics and combined preparations on the hemolytic activity of Rickettsia prowazekii].
    Klimchuk ND
    Mikrobiol Zh; 1978; 40(1):80-4. PubMed ID: 416326
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of tetracycline and rifampicin on Rickettsia prowazekii and Rickettsia sibirica].
    Kashliaev TK; Kekcheeva NG
    Antibiotiki; 1982; 27(9):678-81. PubMed ID: 6816142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.